Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development

Oncogene

Volumn 33, Issue 31, 2014, Pages 4050-4059

  Tan, J ^a,b   Buache, E ^a   Alpy, F ^a   Daguenet, E ^a   Tomasetto, C L ^a   Ren, G S ^b   Rio, M C ^a,c  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c Equipe Labellisée Ligue National Contre le Cancer   (France)

Author keywords

Breast cancer; Collagen; Epithelial stromal cell crosstalk interaction; Mammary gland postnatal development; MMP 11; Paracrine function

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; STROMELYSIN 3; UVOMORULIN;

ANIMAL EXPERIMENT; ARTICLE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENOTYPE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MAMMARY GLAND FUNCTION; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; WILD TYPE;

MUS;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELLS, CULTURED; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MAMMARY GLANDS, ANIMAL; MATRIX METALLOPROTEINASE 11; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; PARACRINE COMMUNICATION; STROMAL CELLS;

EID: 84905376489     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.434     Document Type: Article

References (56)

1. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002; 3: 207-214.
2. Maskos K, Bode W. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Mol Biotechnol 2003; 25: 241-266.
3. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM et al. A novel metallo-proteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348: 699-704.
4. Andarawewa KL, Motrescu ER, Chenard MP, Gansmuller A, Stoll I, Tomasetto C et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 2005; 65: 10862-10871.
5. Basset P, Bellocq JP, Lefebvre O, Noel A, Chenard MP, Wolf C et al. Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol 1997; 26: 43-53.
6. Motrescu ER, Rio MC. Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle. Biol Chem 2008; 389: 1037-1041.
7. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H. Hepa-tocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 2003; 9: 68-75.
8. Kren L, Goncharuk VN, Krenova Z, Stratil D, Hermanova M, Skrickova J et al. Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies. Cesk Patol 2006; 42: 16-19.
9. Zhao ZS, Chu YQ, Ye ZY, Wang YY, Tao HQ. Overexpression of matrix metallo-proteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol 2010; 41: 686-696.
10. Pedersen G, Saermark T, Kirkegaard T, Brynskov J. Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium. Clin Exp Immunol 2009; 155: 257-265.
11. Kwon YJ, Hurst DR, Steg AD, Yuan K, Vaidya KS, Welch DR et al. Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERalpha negative breast cancer cell lines. Clin Exp Metastasis 2011; 28: 437-449.
12. Noel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Mareel M et al. Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest 1996; 97: 1924-1930.
13. Wu E, Mari BP, Wang F, Anderson IC, Sunday ME, Shipp MA. Stromelysin-3 suppresses tumor cell apoptosis in a murine model. J Cell Biochem 2001; 82: 549-555.
14. Tan J, Buache E, Chenard MP, Dali-Youcef N, Rio MC. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int J Dev Biol 2011; 55: 851-859.
15. Couldrey C, Moitra J, Vinson C, Anver M, Nagashima K, Green J. Adipose tissue: a vital in vivo role in mammary gland development but not differentiation. Dev Dyn 2002; 223: 459-468.
16. Landskroner-Eiger S, Park J, Israel D, Pollard JW, Scherer PE. Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes. Dev Biol 2010; 344: 968-978.
17. Ching S, Kashinkunti S, Niehaus MD, Zinser GM. Mammary adipocytes bioactivate 25-hydroxyvitamin D(3) and signal via vitamin D(3) receptor, modulating mammary epithelial cell growth. J Cell Biochem 2011; 112: 3393-3405.
18. Pavlovich AL, Manivannan S, Nelson CM. Adipose stroma induces branching morphogenesis of engineered epithelial tubules. Tissue Eng Part A 2010; 16: 3719-3726.
19. Ucar A, Vafaizadeh V, Jarry H, Fiedler J, Klemmt PA, Thum T et al. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet 2010; 42: 1101-1108.
20. McCave EJ, Cass CA, Burg KJ, Booth BW. The normal microenvironment directs mammary gland development. J Mammary Gland Biol Neoplasia 2010; 15: 291-299.
21. Naylor MJ, Ormandy CJ. Mouse strain-specific patterns of mammary epithelial ductal side branching are elicited by stromal factors. Dev Dyn 2002; 225: 100-105.
22. Khokha R, Werb Z. Mammary gland reprogramming: metalloproteinases couple form with function. Cold Spring Harb Perspect Biol 2011; 3: a004333.
23. Hovey RC, Aimo L. Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia 2010; 15: 279-290.
24. Hennighausen L, Robinson GW. Signaling pathways in mammary gland development. Dev Cell 2001; 1: 467-475.
25. Green KA, Lund LR. ECM degrading proteases and tissue remodelling in the mammary gland. Bioessays 2005; 27: 894-903.
26. Masson R, Lefebvre O, Noel A, Fahime ME, Chenard MP, Wendling C et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 1998; 140: 1531-1541.
27. Lefebvre O, Wolf C, Limacher JM, Hutin P, Wendling C, LeMeur M et al. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 1992; 119: 997-1002.
28. Witty JP, Wright JH, Matrisian LM. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995; 6: 1287-1303.
29. Sternlicht MD. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 2006; 8: 20129.
30. Kurley SJ, Bierie B, Carnahan RH, Lobdell NA, Davis MA, Hofmann I et al. p120-catenin is essential for terminal end bud function and mammary morphogenesis. Development 2012; 139: 1754-1764.
31. Mailleux AA, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge JS. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell 2007; 12: 221-234.
32. Cannata D, Lann D, Wu Y, Elis S, Sun H, Yakar S et al. Elevated circulating IGF-I promotes mammary gland development and proliferation. Endocrinology 2010; 151: 5751-5761.
33. Lijnen HR, Van HB, Frederix L, Rio MC, Collen D. Adipocyte hypertrophy in stro-melysin-3 deficient mice with nutritionally induced obesity. Thromb Haemost 2002; 87: 530-535.
34. Deome KB, Faulkin Jr. LJ, Bern HA, Blair PB. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959; 19: 515-520.
35. Edwards PA. The use of transplanted mammary gland to study cancer signalling pathways. Adv Exp Med Biol 2000; 480: 163-167.
36. Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC, Werb Z. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 2005; 132: 3923-3933.
37. Fata JE, Mori H, Ewald AJ, Zhang H, Yao E, Werb Z et al. The MAPK(ERK-1, 2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev Biol 2007; 306: 193-207.
38. Kannan R, Ruff M, Kochins JG, Manly SP, Stoll I, El Fahime M et al. Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors. Protein Expr Purif 1999; 16: 76-83.
39. Hinck L, Silberstein GB. Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res 2005; 7: 245-251.
40. Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 2006; 314: 298-300.
41. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 2008; 14: 570-581.
42. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001; 128: 3117-3131.
43. Mori H, Lo AT, Inman JL, Alcaraz J, Ghajar CM, Mott JD et al. Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin beta1. Development 2013; 140: 343-352.
44. Keely PJ, Wu JE, Santoro SA. The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 1995; 59: 1-13.
45. Dhimolea E, Maffini MV, Soto AM, Sonnenschein C. The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. Biomaterials 2010; 31: 3622-3630.
46. Motrescu ER, Blaise S, Etique N, Messaddeq N, Chenard MP, Stoll I et al. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 2008; 27: 6347-6355.
47. Aigner T, Hambach L, Soder S, Schlotzer-Schrehardt U, Poschl E. The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion. Biochem Biophys Res Commun 2002; 290: 743-748.
48. Lamande SR, Morgelin M, Adams NE, Selan C, Allen JM. The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells. J Biol Chem 2006; 281: 16607-16614.
49. Wolf K, Friedl P. Extracellular matrix determinants of proteolytic and non-pro-teolytic cell migration. Trends Cell Biol 2011; 21: 736-744.
50. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH et al. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 2001; 61: 984-990.
51. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ et al. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 2003; 162: 1123-1133.
52. Lanigan F, O'Connor D, Martin F, Gallagher WM. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci 2007; 64: 3159-3184.
53. Khialeeva E, Lane TF, Carpenter EM. Disruption of reelin signaling alters mammary gland morphogenesis. Development 2011; 138: 767-776.
54. Noel A, Boulay A, Kebers F, Kannan R, Hajitou A, Calberg-Bacq CM et al. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 2000; 19: 1605-1612.
55. Holtz B, Cuniasse P, Boulay A, Kannan R, Mucha A, Beau F et al. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis. Biochemistry 1999; 38: 12174-12179.
56. Lo AT, Mori H, Mott J, Bissell MJ. Constructing three-dimensional models to study mammary gland branching morphogenesis and functional differentiation. J Mammary Gland Biol Neoplasia 2012; 17: 103-110.